Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaleon Share News (HLN)

Share Price Information for Haleon (HLN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 328.70
Bid: 328.60
Ask: 328.80
Change: 1.80 (0.55%)
Spread: 0.20 (0.061%)
Open: 328.50
High: 330.70
Low: 327.80
Prev. Close: 326.90
HLN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: Marshalls downgrades outlook on earnings hit

Mon, 18th Mar 2024 08:49

(Alliance News) - Stock prices in London opened mixed on Monday, with the FTSE 100 treading water, as investors look ahead to a week of interest rate decisions.

The FTSE 100 index opened up 3.59 points at 7,731.01. The FTSE 250 was down 39.45 points, 0.2%, at 19,473.46, and the AIM All-Share was down 2.29 points, 0.3%, at 736.02.

The Cboe UK 100 was up slightly at 774.01, the Cboe UK 250 was down 0.1% at 16,893.02, and the Cboe Small Companies was up 0.1% at 14,766.29.

In European equities on Monday, the CAC 40 in Paris was up marginally, while the DAX 40 in Frankfurt was up 0.2%.

In Japan on Monday, the Nikkei 225 index in Tokyo was up 2.7%.

Major Japanese media and economists are now betting that the Bank of Japan will drop its negative interest rate policy.

The central bank is scheduled to start a two-day policy board meeting on Monday, with Governor Kazuo Ueda's press conference scheduled for Tuesday afternoon.

Citing "sources close to the matter", the Japan Times said the BoJ's policymakers have the requisite confidence that a "virtuous cycle" of wage growth and price hikes is taking place.

Analysts at ING said "the BoJ’s hike or hold decision is a 50-50 affair."

"Looking only at the macro picture, we think the BoJ is more likely to wait until April to take a closer look at consumer developments. However, some media reports in Japan have quite clearly suggested the hike will come tomorrow," ING added.

An interest rate decision from the US Federal Reserve will follow on Wednesday, with the Bank of England making its own decision the following day.

Both are expected to keep interest rates unchanged.

In China, the Shanghai Composite closed up 1.0%, while the Hang Seng index in Hong Kong was was up 0.1% in late dealings. The S&P/ASX 200 in Sydney closed up 0.1%

The pound was quoted at USD1.2745 early on Monday in London, up compared to USD1.2735 at the equities close on Friday. The euro stood at USD1.0896, higher against USD1.0889. Against the yen, the dollar was trading at JPY149.07, higher compared to JPY149.04.

In the FTSE 100, Haleon lost 2.0%.

Haleon said that Pfizer intends to sell approximately 630 million Haleon ordinary shares through a public offer, worth GBP315 million.

On completion, the sale is expected to reduce Pfizer's interest in Haleon to approximately 24% from 32%.

In the FTSE 250, Marshalls lost 12%.

Marshalls reported that revenue in 2023 fell to GBP671.2 million from GBP719.4 million a year earlier. Pretax profit tumbled by 40% to GBP41.0 million from GBP47.9 million.

On the back of the results, Marshalls lowered its final dividend by 42% to 5.7p from 9.9p. This brings the full year dividend to 8.3p, down 47% from 15.6p.

Marshalls said that revenue in the first two months of the year was lower than 2023 and reflects the continued weakness seen in the second half of last year.

"In line with recent sentiment of UK economic and industry forecasts, the board expects activity levels to remain subdued in the first half of the year followed by a modest recovery in the second half as the macro-economic environment progressively improves. The start of this recovery is now expected to be slower and more modest than previously assumed," the company explained.

Therefore, Marshalls believes that revenue in 2024 will be lower than previously expected and that profit will now be at a similar level to 2023.

Bytes Technology lost 11%.

Bytes Technology updated markets on its financial year ended February 29. The company said it delivered growth "comfortably" in double digits in its key metrics of gross profit and adjusted operating profit, and cash conversion in line with its target of 100%, resulting in a cash position of approximately GBP89 million at the year end.

In February, Bytes was hit by the shock resignation of Chief Executive Neil Murphy.

The company said Murphy had resigned with immediate effect after disclosing to the board a number of undisclosed trades in the company. The trades were not disclosed to the company or the market in compliance with the PDMR disclosure requirements, it added.

On Monday the company said: "Given Mr Murphy's longstanding leadership position in the company, the board of directors is saddened as well as shocked by Mr Murphy's actions, which it finds hard to comprehend. His actions were entirely at odds with the values of openness, honesty, and transparency which have been and which remain central to the group's culture and to its ongoing success."

On AIM, Focusrite fell 35%.

For financial 2024, ending August 31, the music and audio products firm expects revenue to be at least GBP155 million. In financial 2023, revenue amounted to GBP178.5 million.

"HY24 performance has been impacted by similar factors across the group's geographic regions. The Content Creation market globally continues to struggle due to a number of macroeconomic issues. Content Creation revenue in Asia have shown particular continued weakness with now 18 months of continuous decline, the largest negative impacts being in China and Japan, and no improvement is now assumed for the remainder of the year," Focusrite said.

In the US on Friday, Wall Street ended lower, with the Dow Jones Industrial Average down 0.5%, the S&P 500 down 0.7% and the Nasdaq Composite down 1.0%.

Brent oil was quoted at USD85.90 a barrel early in London on Monday, up from USD85.33 late Friday.

Gold was quoted at USD2,153.20 an ounce, lower against USD2,162.90.

Still to come on Monday's economic calendar has a eurozone consumer price reading at 1000 GMT, as well as trade balance data.

By Sophie Rose, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
6 Feb 2024 12:24

Futura Medical shares surge after "transformational year"

(Alliance News) - Futura Medical PLC on Tuesday reported its first revenues in 2023, thanks to the successful global roll-out of Eroxon.

Read more
2 Feb 2024 14:25

IN BRIEF: Mondelez appoints Haleon CEO Brian McNamara as board member

Mondelez International Inc - Chicago, Illinois-based food and beverage company - Appoints Haleon PLC's Chief Executive Officer Brian McNamara to its board from yesterday. "We are pleased to welcome Brian to our board. His breadth and depth of expertise in all aspects of consumer products leadership – including supply chain, brand marketing, customer engagement and more – will provide valuable insight and strategic input to our team," said Mondelez CEO Dirk Van de Put. McNamara’s appointment expands the size of the company's board to 11 members, adds Mondelez.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
30 Jan 2024 09:32

LONDON BROKER RATINGS: BoA cuts Barratt, Persimmon; ups Taylor Wimpey

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
25 Jan 2024 12:07

LONDON MARKET MIDDAY: Stocks down before expected ECB hold and US data

(Alliance News) - Stock prices in London were down at midday on Thursday, in tepid trade ahead of an expected interest rate hold from the European Central Bank and a US gross domestic product reading.

Read more
25 Jan 2024 08:47

LONDON MARKET OPEN: Stocks drift lower before ECB decision

(Alliance News) - Stock prices in London opened lower on Thursday, amidst uncertainty ahead of the European Central Bank rate call.

Read more
25 Jan 2024 08:39

TOP NEWS: Haleon sells ChapStick brand for USD430 million in cash

(Alliance News) - Haleon PLC on Thursday it has agreed to sell the ChapStick lip balm brand to Suave Brands Co for around USD430 million in cash.

Read more
25 Jan 2024 07:41

LONDON BRIEFING: Haleon sells ChapStick; RS reports market weakness

(Alliance News) - Stocks in London are called slightly lower on Thursday, ahead of a central bank decision in the eurozone, and US economic growth data.

Read more
25 Jan 2024 07:14

Haleon offloads ChapStick brand for $430m

(Sharecast News) - Consumer health group Haleon, the company behind Sensodyne toothpaste, Panadol and Advil painkillers, has announced it is selling the ChapStick lip balm brand for $430m.

Read more
24 Jan 2024 16:31

London close: Stocks rise on positive news from China

(Sharecast News) - London markets finished with a positive performance on Wednesday, driven by gains in the mining sector following China's announcement of an upcoming reduction in the reserve requirement ratio for banks.

Read more
24 Jan 2024 15:58

Broker tips: Greggs, Haleon

(Sharecast News) - Numis initiated coverage of Greggs on Wednesday with a 'hold' rating and 2,560p price target as it said growth was "baked in".

Read more
24 Jan 2024 15:08

Private equity firm Yellow Wood close to deal to acquire ChapStick-sources

Jan 24 (Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.

Read more
24 Jan 2024 12:32

JPMorgan puts Haleon on negative catalyst watch

(Sharecast News) - JPMorgan has placed consumer health company Haleon on negative catalyst watch ahead of its annual report next month, saying volume and earnings risks will weigh on the stock's rating.

Read more
24 Jan 2024 09:11

LONDON BROKER RATINGS: UBS cuts BAT to 'neutral'; Barclays cuts Senior

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
22 Jan 2024 21:22

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.